Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-10-16
2007-10-16
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S092000, C549S434000, C548S161000, C548S263800, C548S469000, C546S337000, C544S297000, C544S360000, C544S400000
Reexamination Certificate
active
10531406
ABSTRACT:
The invention provides compoods and methods for treating cell proliferative-diseases. The invention provides new inhibitors of histone deacetylase enzymatic activity, compositions of the compounds comprising the inhibitors and a pharmaceutically acceptable carrier, excipient, or diluent, and methods of using the compounds to inhibit cellular proliferation in vitro and therapeutically.
REFERENCES:
patent: 5366878 (1994-11-01), Pederson et al.
patent: 5635377 (1997-06-01), Pederson et al.
patent: 5652355 (1997-07-01), Metelev et al.
patent: 6174905 (2001-01-01), Suzuki et al.
patent: 0 847 992 (1998-06-01), None
patent: 258863/96 (1996-09-01), None
patent: WO 01/38322 (2001-05-01), None
patent: WO 01/70675 (2001-09-01), None
Weidle, U. H.; Grossmann, A., “XP-001098720—Inhibition of Histone Deacetylases: a New Strategy to Target Epigenetic Modifications for Anticancer Treatment”,Anticancer Research 20, 2000, pp. 1471-1486.
Csordas, Adam., “On the Biological Role of Histone Acetylation,”Biochem. J.,vol. 265 (1990) pp. 23-38.
Taunton, Jack, et al., “A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p,”Science,vol. 272 (1996) pp. 408-411.
Grozinger, Christina M., et al., “Three Proteins Define a Class of Human Histone Deacetylases Related to Yeast Hdalp,”PNAS,vol. 96 (1999) pp. 4868-4873.
Kao, Hung-Ying, et al., “Isolation of a Novel Histone Deacetylase Reveals that Class I and Class II Deacetylases Promote SMRT-Mediated Repression,”Genes&Development,vol. 14 (2000) pp. 55-66.
Van den Wyngaert, Ilse, et al. “Cloning and Characterization of Human Histone Deacetylase 8,”FEBS Letters,vol. 478 (2000) pp. 77-83.
Richon, Victoria M., et al. “A Class of Hybrid Polar Inducers of Transformed Cell Differentiation Inhibits Histone Deacetylases,”PNAS,vol. 95 (1998) pp. 3003-3007.
Yoshida, Minoru & Beppu, Teruhiko, “Reversible Arrest of Proliferation of Rat 3Y1 Fibroblasts in Both the G1 and G2 Phases by Trichostatin A,”Experimental Cell Research,vol. 177(1988) pp. 122-131.
Finnin, Michael S., et al., “Structures of a Histone Deacetylase Homologue Bound to the TSA and SAHA Inhibitors,”Nature,vol. 401 (19999) pp. 188-193.
Yoshida, Minoru, et al., “Potent and Specific Inhibition of Mammalian Histone Deacetylase BothIn VivoandIn Vitroby Trichostatin A,”J. Biol. Chem.,vol. 265, No. 28 (1990) pp. 17174-17179.
Ramchandani, Shyam, et al., “Inhibition of Tumerigenesis by a Cytosine-DNA, Methyltransferase, Antisense Oligodeoxynucleotide,”PNAS,vol. 94 (1997) pp. 684-689.
Pon, Richard T., “Solid Phase Supports for Oligonucleotide Synthesis,”Methods in Molecular Biology,vol. 20 (1993) pp. 465-496.
Meyer, Thomas, et al., “A Derivative of Staurosporine (CGP 41 251) Shows Selectivity for Protein Kinase C Inhibition andIn VitroAnti-Proliferative as Well asIn VivoAnti-Tumor Activity,”Int. J. Cancer,vol. 43 (1989) pp. 851-856.
Delorme Daniel
Gaudette Frederic
Raeppel Stephane
Kumar Shailendra
McDonnell Boehnen & Hulbert & Berghoff LLP
Methylgene Inc.
LandOfFree
Inhibitors of histone deacetylase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of histone deacetylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of histone deacetylase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822938